<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03567486</url>
  </required_header>
  <id_info>
    <org_study_id>DCT_2017_18</org_study_id>
    <nct_id>NCT03567486</nct_id>
  </id_info>
  <brief_title>Predictive Factors of Visual Recovery After Paraoptic Tumors Removal</brief_title>
  <acronym>PRONOPTIC</acronym>
  <official_title>Paraoptic Tumors : Study of the Radiological, Ophthalmological and Intraoperative Predictive Factors of Visual Recovery After Neurosurgical Removal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Paraoptic tumors - including mostly sellar meningiomas, pituitary gland adenomas and
      craniopharyngiomas - classically affect the visual function. Some preoperative factors,
      determined on retrospective studies, are known to constitute bad prognostic factors, such as
      duration of symptoms and retinal nerve fiber layer thinning on OCT. We propose to perform a
      single center prospective study in which detailed preoperative ophthalmological and
      radiological criteria will be collected before surgery. Intraoperative information will be
      noted as well. All these data will be statistically examined regarding the postoperative
      visual recovery at 3, 6 and 12 months
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2017</start_date>
  <completion_date type="Anticipated">December 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 18, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>variation of Visual field</measure>
    <time_frame>between before surgery and 6 months postoperatively</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Tuberculum Sellae Meningioma</condition>
  <arm_group>
    <arm_group_label>Tuberculum sellae meningiomas</arm_group_label>
    <description>Adult patient suffering from tuberculum sellae meningiomas with surgical treatment</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        tuberculum sellae meningioma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  tuberculum sellae meningioma surgical indication

        Exclusion Criteria:

          -  surgical contra indication MRI contra indication optical disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dorian Chauvet</last_name>
    <phone>+33 148036915</phone>
    <email>dchauvet@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorian Chauvet</last_name>
      <phone>+33 148036915</phone>
      <email>dchauvet@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 13, 2018</study_first_submitted>
  <study_first_submitted_qc>June 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningioma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

